Staff Neurologist, Neurological Institute's Mellen Center for Multiple Sclerosis, Cleveland Clinic
ENSEMBLE Study Results, Ocrelizumab as Promising Early Treatment for MS: Robert A. Bermel, MD
The director of the Mellen Center for MS at Cleveland Clinic talked about the ENSEMBLE study results that were presented at the 2023 AAN Annual Meeting. [WATCH TIME: 6 minutes]
Linking the Latest Research to Clinical Care in MS: Robert Bermel, MD
The director of the Mellen Center for MS at Cleveland Clinic offered an overview of the State of the Science Summit that was held on November 10, 2022, featuring a panel of expert clinicians. [WATCH TIME: 4 minutes]
The Current State and Future Promise of Neurology
The importance of addressing disorders of the brain cannot be overstated, and doing so will be essential to our generation and generations to come.
2 Clarke Drive Cranbury, NJ 08512